Íslenska
Search
My pages
Close

Greinasafn

09. Who is responsible for the payment of a MAH transfer? Current or proposed MAH?

08. What does a transfer of a marketing authorisation to a new MAH cost?

07. Is it possible to submit any variations while there is an ongoing MAH transfer procedure?

06. Can a change in MA transfer application be submitted while variations affecting the medicinal product are still pending?

05. Notification of a new representative – applies to all types of authorisation procedures

04. Once the MA is transferred to the new owner, for how long can stocks be sold using the details of the previous MA holder?

03. What is the estimated IMA´s timeframe for approval of a Marketing Authorisation Holder transfer?

02. Upon transfer of Marketing Authorisation for a medicinal product who shall apply for the transfer: the current or the proposed Marketing Authorisation Holder?

01. Transfer of a marketing authorisation for a medicinal product to a third party – applies to national, as well as DCP and MRP authorisations.